Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

NCT00026520 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NETWORK

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: recombinant interferon alfa
DRUG: thalidomide

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]